Navigation Links
Omnicare (NYSE: OCR) Agrees to Pay United States $120 Million to Settle False Claims Act Suit Alleging Kickbacks
Date:10/24/2013

NEW YORK, Oct. 24, 2013 /PRNewswire/ -- Sanford Heisler LLP, a leading public interest law firm, teamed with three other law firms in settling a whistleblower ("qui tam") lawsuit Omnicare, Inc. (NYSE: OCR), the nation's largest provider of pharmacy services to nursing home patients. Under the agreement, Omnicare has agreed to pay the United States $120 Million to resolve kickback and false-claims allegations brought by Donald Gale, an Ohio pharmacist who worked for the company's Wadsworth, Ohio pharmacy from 1993 until 2010. 

Mr. Gale sued Omnicare pursuant to the federal False Claims Act.  The agreement between Mr. Gale and Omnicare avoids a jury trial scheduled for Monday, October 28, but will not be final until it is approved by the Civil Division of the United States Department of Justice. Omnicare acknowledged the settlement in SEC filings this week, indicating a material impact on the corporation.

Mr. Gale's complaint alleges Omnicare engaged in a form of kickback scheme known as "swapping."  Omnicare paid nursing home owners kickbacks in the form of discounted prescription drugs for Medicare Part A inpatients. The nursing homes are financially responsible for Part A patients' medical care because Medicare pays a flat fee to the facility.  Omnicare offered the nursing homes daily, "per diem" pricing.  Mr. Gale claims that Omnicare gave the discounts intending that the nursing homes would refer, or "swap," their non-Part A patients, most of whom participate in the Medicare Part D prescription-drug benefit program, to Omnicare.  Omnicare then charged full price for their prescription drugs and other pharmacy services.  The HHS Office of Inspector General has made clear since 1999, when Medicare Part A services were converted to the "Prospective Payment system," that swapping is prohibited by the Anti-Kickback Statute.  Mr. Gale's complaint alleges that the per diem pricing for hundreds of facilities was substantially below the fair market value of the goods provided, and that this violated the Medicare Anti-Kickback Statute and the False Claims Act. 

Omnicare has settled prior False Claims Act cases both for paying and receiving kickbacks, and since 2006, has operated under Corporate Integrity Agreements with the HHS Office of Inspector General. 

Mr. Gale was the General Manager of one of Omnicare's pharmacies in Wadsworth, Ohio.  His civil complaint was filed under seal in January 2010.  The case was unsealed in 2011, after the U.S. Attorney for the Northern District of Ohio elected not to intervene.  This decision, which occurs in about 85% of False Claims Act cases, cleared the way for Mr. Gale to pursue the case on behalf of the taxpayers.  The case has been vigorously litigated since early 2012.

The False Claims Act, also called "Lincoln's Law," was first signed by President Lincoln in 1863. Amendments to the law in 1986 made it the federal government's primary weapon against fraud and abuse by government contractors. The statute permits a private citizen like Mr. Gale to bring a case in the name of the United States, and to recover a portion of any recovery. If the Justice Department approves the Omnicare settlement, Mr. Gale's share of the proceeds will be 25 to 30% of the federal recovery.

"This settlement stands as a powerful example of how the False Claims Act empowers Americans to help fight fraud on the government and American taxpayers. It shows that ordinary citizens who care about following the law and doing the right thing can make a difference," said Ross Brooks, head of Sanford Heisler's False Claims Act practice and one of Mr. Gale's lawyers in the case.

"Mr. Gale has achieved a remarkable settlement on behalf of the United States, which he has asked the Justice Department to approve.  This settlement," Brooks added, "should send a clear message to companies who would engage in government fraud that whistleblowers have the ability to go the distance when necessary to return defrauded taxpayer funds to the federal treasury."  Brooks noted that this is one of the largest settlements of a qui tam case in which the Justice Department declined to intervene.

The False Claims Act creates a unique and powerful public/private partnership for the pursuit of fraud claims by whistleblowers.  Mr. Gale's legal team worked in close coordination with attorneys of the Department of Justice's Civil Division in Washington and the Office of Northern District of Ohio United States Attorney Steven M. Dettlebach.

The case remains pending until final resolution before United States District Judge James S. Gwin of the United States District Court for the Northern District of Ohio.

The legal team at Sanford Heisler LLP included Ross B. Brooks, Rolando G. Marquez and Michael D. Palmer in the firm's New York office.  The Sanford Heisler team was co-counsel to attorneys from Morgan Verkamp, LLC, Calfee, Halter & Griswold LLP and Berger & Montague, PC.

Media Contact:  Jamie Moss, newsPRos, 201 788 0142


'/>"/>
SOURCE Sanford Heisler LLP
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Berger & Montague, P.C. Announces That Omnicare, Inc. Agrees to Pay $120 Million to Settle Kickback Allegation
2. Omnicare and AmerisourceBergen Under Review: Drugs Company Stocks Hit New Highs
3. ResMed Patent Infringement Case Against BMC Advances: International Trade Commission Agrees to Investigate
4. Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. for $19.75 Per Share in Cash
5. Ajinomoto Co., Inc. Agrees To Acquire Althea Technologies, Inc.
6. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
7. French Government Agrees to Fund Study of the PneumRx RePneu Lung Volume Reduction Coil
8. Sonendo Agrees To Terms For Up To $20 Million In Financing
9. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
10. Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
11. Hospira Launches Q Core Sapphire Infusion System in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... 2017 , ... Coveros, a leader in agile coaching services ... by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile Transformation ... Agile methodologies in a consistent and high value manner across CMS programs. Coveros ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally ... care, have expanded their existing home health joint venture through an agreement, effective ... operating a joint venture home health company with Asante, delivering clinically integrated care, ...
Breaking Medicine News(10 mins):